相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unchanged mitochondrial organization and compartmentation of high-energy phosphates in creatine-deficient GAMT-/- mouse hearts
Jelena Branovets et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
S-Nitrosylation of Dynamin-Related Protein 1 Mediates Mutant Huntingtin-Induced Mitochondrial Fragmentation and Neuronal Injury in Huntington's Disease
Florian Haun et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: Implications in Huntington's disease
Rajat Sandhir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
3-Nitropropionic acid induces autophagy by forming mitochondrial permeability transition pores rather than activatiing the mitochondrial fission pathway
Maria E. Solesio et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Mutant huntingtin affects endocytosis in striatal cells by altering the binding of AP-2 to membranes
Janina E. Borgonovo et al.
EXPERIMENTAL NEUROLOGY (2013)
Glutathione peroxidase activity is neuroprotective in models of Huntington's disease
Robert P. Mason et al.
NATURE GENETICS (2013)
QUERCETIN UP-REGULATES MITOCHONDRIAL COMPLEX-I ACTIVITY TO PROTECT AGAINST PROGRAMMED CELL DEATH IN ROTENONE MODEL OF PARKINSON'S DISEASE IN RATS
S. S. Karuppagounder et al.
NEUROSCIENCE (2013)
Oxidizing Effects of Exogenous Stressors in Huntingtons Disease Knock-in Striatal CellsuProtective Effect of Cystamine and Creatine
Marcio Ribeiro et al.
TOXICOLOGICAL SCIENCES (2013)
Off label use of lithium in the treatment of Huntington's disease: A case series
Vijay Danivas et al.
INDIAN JOURNAL OF PSYCHIATRY (2013)
Shaping the role of mitochondria in the pathogenesis of Huntington's disease
Veronica Costa et al.
EMBO JOURNAL (2012)
Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity
Puneet Kumar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease
Ulziibat P. Shirendeb et al.
HUMAN MOLECULAR GENETICS (2012)
The axonal transport of mitochondria
William M. Saxton et al.
JOURNAL OF CELL SCIENCE (2012)
N-Acetylcysteine Reverses Mitochondrial Dysfunctions and Behavioral Abnormalities in 3-Nitropropionic Acid-Induced Huntington's Disease
Rajat Sandhir et al.
NEURODEGENERATIVE DISEASES (2012)
Modulation of Astrocytic Mitochondrial Function by Dichloroacetate Improves Survival and Motor Performance in Inherited Amyotrophic Lateral Sclerosis
Ernesto Miquel et al.
PLOS ONE (2012)
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage
Ulziibat Shirendeb et al.
HUMAN MOLECULAR GENETICS (2011)
Myelination and Axonal Electrical Activity Modulate the Distribution and Motility of Mitochondria at CNS Nodes of Ranvier
Nobuhiko Ohno et al.
JOURNAL OF NEUROSCIENCE (2011)
The Melatonin MT1 Receptor Axis Modulates Mutant Huntingtin-Mediated Toxicity
Xin Wang et al.
JOURNAL OF NEUROSCIENCE (2011)
Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity
Wenjun Song et al.
NATURE MEDICINE (2011)
Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli
Veronica Costa et al.
EMBO MOLECULAR MEDICINE (2010)
Loss of MARCH5 mitochondrial E3 ubiquitin ligase induces cellular senescence through dynamin-related protein 1 and mitofusin 1
Yong-Yea Park et al.
JOURNAL OF CELL SCIENCE (2010)
Activity-Dependent Regulation of Mitochondrial Motility by Calcium and Na/K-ATPase at Nodes of Ranvier of Myelinated Nerves
Chuan Li Zhang et al.
JOURNAL OF NEUROSCIENCE (2010)
Mitofusin 2 Is Necessary for Transport of Axonal Mitochondria and Interacts with the Miro/Milton Complex
Albert Misko et al.
JOURNAL OF NEUROSCIENCE (2010)
Visualization of melatonin's multiple mitochondrial levels of protection against mitochondrial Ca2+-mediated permeability transition and beyond in rat brain astrocytes
Mei-Jie Jou et al.
JOURNAL OF PINEAL RESEARCH (2010)
S-Nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration
Tomohiro Nakamura et al.
MITOCHONDRION (2010)
Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease
Robert Schwarcz et al.
PROGRESS IN NEUROBIOLOGY (2010)
Control of mitochondrial transport and localization in neurons
Andrew F. MacAskill et al.
TRENDS IN CELL BIOLOGY (2010)
Inhibitory modulation of the mitochondrial permeability transition by minocycline
Anne Gieseler et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway
G. Liot et al.
CELL DEATH AND DIFFERENTIATION (2009)
Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease
Karina Acevedo-Torres et al.
DNA REPAIR (2009)
Impairment of mitochondrial function by minocycline
Kathleen Kupsch et al.
FEBS JOURNAL (2009)
The Miro GTPases: At the heart of the mitochondrial transport machinery
Katarina Reis et al.
FEBS LETTERS (2009)
Mitochondrial Gene Therapy Augments Mitochondrial Physiology in a Parkinson's Disease Cell Model
Paula M. Keeney et al.
HUMAN GENE THERAPY (2009)
Effects of overexpression of Huntingtin proteins on mitochondrial integrity
Hongmin Wang et al.
HUMAN MOLECULAR GENETICS (2009)
Impaired PGC-1α function in muscle in Huntington's disease
Rajnish K. Chaturvedi et al.
HUMAN MOLECULAR GENETICS (2009)
Delayed onset of the diurnal melatonin rise in patients with Huntington's disease
N. Ahmad Aziz et al.
JOURNAL OF NEUROLOGY (2009)
The Role of Melatonin in Sleep Disturbances in End-Stage Huntington's Disease
J. Alders et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2009)
Decreased BDNF Levels Are a Major Contributor to the Embryonic Phenotype of Huntingtin Knockdown Zebrafish
Heike Diekmann et al.
JOURNAL OF NEUROSCIENCE (2009)
KIF5B Motor Adaptor Syntabulin Maintains Synaptic Transmission in Sympathetic Neurons
Huan Ma et al.
JOURNAL OF NEUROSCIENCE (2009)
Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma
I. Tasset et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2009)
Melatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells
Wilaiwan Wisessmith et al.
JOURNAL OF PINEAL RESEARCH (2009)
GTPase dependent recruitment of Grif-1 by Miro1 regulates mitochondrial trafficking in hippocampal neurons
Andrew F. MacAskill et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2009)
Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats
Mritunjay Pandey et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Evidence of calpain/cdk5 pathway inhibition by lithium in 3-nitropropionic acid toxicity in vivo and in vitro
N. Crespo-Biel et al.
NEUROPHARMACOLOGY (2009)
Disruption of Mitochondrial DNA Replication in Drosophila Increases Mitochondrial Fast Axonal Transport In Vivo
Rehan M. Baqri et al.
PLOS ONE (2009)
Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity
Yoko Nekooki-Machida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status
Harikesh Kalonia et al.
NEUROSCIENCE BULLETIN (2009)
Memantine Blocks Mitochondrial OPA1 and Cytochrome c Release and Subsequent Apoptotic Cell Death in Glaucomatous Retina
Won-Kyu Ju et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
A stress sensitive ER membrane-association domain in Huntingtin protein defines a potential role for Huntingtin in the regulation of autophagy
Randy Singh Atwal et al.
AUTOPHAGY (2008)
Effects of memantine on mitochondrial function
Jenna McAllister et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients
Hyemyung Seo et al.
HUMAN MOLECULAR GENETICS (2008)
Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II
Alexandra Benchoua et al.
HUMAN MOLECULAR GENETICS (2008)
N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking
Adam L. Orr et al.
JOURNAL OF NEUROSCIENCE (2008)
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
Rachelle S. Doody et al.
LANCET (2008)
Evaluation of Dimebon in cellular model of Huntington's disease
Jun Wu et al.
MOLECULAR NEURODEGENERATION (2008)
Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria
G. M. Cereghetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease
Herman B. Fernandes et al.
JOURNAL OF NEUROSCIENCE (2007)
Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death
J. Thomas Cribbs et al.
EMBO REPORTS (2007)
Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients
Chiung-Mei Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division
Mariusz Karbowski et al.
JOURNAL OF CELL BIOLOGY (2007)
Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission
Naoko Taguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and huntingtin aggregates
Hirokazu Fukui et al.
HUMAN MOLECULAR GENETICS (2007)
Lamotrigine inhibition of rotenone- or 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death
Yun Jeong Kim et al.
BRAIN RESEARCH BULLETIN (2007)
Mitochondria frozen with trehalose retain a number of biological functions and preserve outer membrane integrity
R. Yamaguchi et al.
CELL DEATH AND DIFFERENTIATION (2007)
The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis
Erica Rockabrand et al.
HUMAN MOLECULAR GENETICS (2007)
The SUMO protease SENP5 is required to maintain mitochondrial morphology and function
Rodolfo Zunino et al.
JOURNAL OF CELL SCIENCE (2007)
Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo
Eugenia Trushina et al.
HUMAN MOLECULAR GENETICS (2006)
Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease
Soon-Tae Lee et al.
BRAIN RESEARCH (2006)
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration
Patrick Weydt et al.
CELL METABOLISM (2006)
Evaluation of clinically relevant glutamate pathway inhibitors in in vitro model of Huntington's disease
Jun Wu et al.
NEUROSCIENCE LETTERS (2006)
Transcriptional repression of PGC-α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration
Libin Cui et al.
CELL (2006)
Aspirin induces apoptosis through the inhibition of proteasome function
Priyanka Dikshit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Melatonin protects against hydrogen peroxide-induced cell death signaling in SH-SY5Y cultured cells: involvement of nuclear factor kappa B, Bax and Bcl-2
Banthit Chetsawang et al.
JOURNAL OF PINEAL RESEARCH (2006)
Oxidative stress in skin fibroblasts cultures of patients with Huntington's disease
Pilar del Hoyo et al.
NEUROCHEMICAL RESEARCH (2006)
Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice
Karen M. Smith et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)
Nitric oxide impairs mitochondrial movement in cortical neurons during hypoxia
SA Zanelli et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Nitric oxide inhibits mitochondrial movement in forebrain neurons associated with disruption of mitochondrial membrane potential
GL Rintoul et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons
DTW Chang et al.
NEUROBIOLOGY OF DISEASE (2006)
Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated Huntingtin
A Benchoua et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Levetiracetam: Antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus
JE Gibbs et al.
EPILEPSIA (2006)
Interaction of huntingtin-associated protein-1 with kinesin light chain - Implications in intracellular trafficking in neurons
JR McGuire et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG
SM Hersch et al.
NEUROLOGY (2006)
Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REG gamma as a therapeutic target
JS Bett et al.
HUMAN MOLECULAR GENETICS (2006)
The axonal transport of mitochondria
PJ Hollenbeck et al.
JOURNAL OF CELL SCIENCE (2005)
3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease
E Brouillet et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Efficacy of levetiracetam in Huntington disease
M de Tommaso et al.
CLINICAL NEUROPHARMACOLOGY (2005)
Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model
T Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses
XF Guo et al.
NEURON (2005)
p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease
BI Bae et al.
NEURON (2005)
Melatonin protects against neuronal damage induced by 3-nitroproplonic acid in rat striatum
E Nam et al.
BRAIN RESEARCH (2005)
Minocycline in phenotypic models of Huntington's disease
K Bantubungi et al.
NEUROBIOLOGY OF DISEASE (2005)
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease
G Gardian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease
AJ Morton et al.
JOURNAL OF NEUROSCIENCE (2005)
Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington's disease individuals
AV Panov et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Paroxetine retards disease onset and progression in huntingtin mutant mice
WZ Duan et al.
ANNALS OF NEUROLOGY (2004)
Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid
TR Rosenstock et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Retinal ganglion cell survival is enhanced by gabapentin-lactam in vitro:: evidence for involvement of mitochondrial KATP channels
A Pielen et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2004)
Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease
M Napolitano et al.
NEUROBIOLOGY OF DISEASE (2004)
Sumol conjugates and participates in mitochondrial substrates mitochondrial fission
Z Harder et al.
CURRENT BIOLOGY (2004)
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease
M Tanaka et al.
NATURE MEDICINE (2004)
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro
E Trushina et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Mitochondrial permeability transition in neuronal damage promoted by Ca2+ and respiratory chain complex II inhibition
EN Maciel et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease
B Zucker et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules
LR Gauthier et al.
CELL (2004)
Neuroprotection in Huntingtons disease:: a 2-year study on minocycline
RM Bonelli et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2004)
Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease
I Túnez et al.
JOURNAL OF PINEAL RESEARCH (2004)
Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic mice
F Norflus et al.
NEUROBIOLOGY OF DISEASE (2004)
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
B Ravikumar et al.
NATURE GENETICS (2004)
Axonal mitochondrial transport and potential are correlated
KE Miller et al.
JOURNAL OF CELL SCIENCE (2004)
Inefficient degradation of truncated polyglutamine proteins by the proteasome
CI Holmberg et al.
EMBO JOURNAL (2004)
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
M Arrasate et al.
NATURE (2004)
Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
E Diguet et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Syntabulin is a microtubule-associated protein implicated in syntaxin transport in neurons
QN Su et al.
NATURE CELL BIOLOGY (2004)
Creatine supplementation in Huntington's disease - A placebo-controlled pilot trial
P Verbessem et al.
NEUROLOGY (2003)
Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons
M Cyr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington's disease mutation
NI Wood et al.
BRAIN RESEARCH BULLETIN (2003)
A Randomized trial of amantadine in Huntington disease
P O'Suilleabhain et al.
ARCHIVES OF NEUROLOGY (2003)
IV amantadine improves chorea in Huntington's disease - An acute randomized, controlled study
C Lucetti et al.
NEUROLOGY (2003)
Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice
A Dedeoglu et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Transcriptional abnormalities in Huntington disease
KL Sugars et al.
TRENDS IN GENETICS (2003)
Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells
W Yang et al.
HUMAN MOLECULAR GENETICS (2002)
Voltage-dependent anion-selective channel (VDAC) interacts with the dynein light chain Tctex 1 and the heat-shock protein PBP74
C Schwarzer et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
Amantadine in Huntington's disease: open-label video-blinded study
C Lucetti et al.
NEUROLOGICAL SCIENCES (2002)
Age-associated mitochondrial oxidative decay:: Improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-α-lipoic acid
JK Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease
MB Bogdanov et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene
O Hansson et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Lipoic acid improves survival in transgenic mouse models of Huntington's disease
OA Andreassen et al.
NEUROREPORT (2001)
Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells
E Smirnova et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
In vitro effects of lithium and nickel at different levels on Neuro-2a mouse Neuroblastoma cells
G Repetto et al.
TOXICOLOGY IN VITRO (2001)
Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease
OA Andreassen et al.
ANNALS OF NEUROLOGY (2001)
Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release
NR Jana et al.
HUMAN MOLECULAR GENETICS (2001)
Mutant huntingtin enhances excitotoxic cell death
MM Zeron et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2001)
Biochemical reactivity of melatonin with reactive oxygen and nitrogen species - A review of the evidence
RJ Reiter et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2001)
Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
JJ Lehman et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice
DX Chen et al.
NATURE MEDICINE (2000)
Increased levels of oxidatively damaged DNA induced by chromium(III) and H2O2:: protection by melatonin and related molecules
WB Qi et al.
JOURNAL OF PINEAL RESEARCH (2000)
Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats
DA Shear et al.
NEUROREPORT (2000)
N-Acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice:: implications for treatment of Parkinson's disease
MM Banaclocha
BRAIN RESEARCH (2000)
3-Nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease
MA La Fontaine et al.
BRAIN RESEARCH (2000)
分享论文
